Canary Speech, Inc. Secures $13 Million Series A Funding Round Led by Cortes Capital
June 12, 2024, 9:36 pm
Location: United States, Utah, Provo
Employees: 11-50
Founded date: 2016
Total raised: $13.58M
Canary Speech, Inc. (Canary), a trailblazer in AI-powered voice biomarker technology, has locked in a hefty $13 million Series A funding round spearheaded by Cortes Capital, LLC. This funding round also saw the participation of Sorenson Communications, LLC., SMK (Japan), and Hackensack Meridian Health. With a robust patent portfolio, Canary stands tall in the industry with nine issued patents safeguarding the use of vocal biomarkers in healthcare. The company is gearing up to expand its team to keep pace with the rapid growth fueled by advancements in artificial intelligence and the healthcare sector's escalating demand for cutting-edge tools.
Canary's vocal biomarker technology, with its API-first approach, boasts a myriad of applications within the healthcare realm. From contact centers to ambient clinical listening, remote patient monitoring, and annual wellness checks, Canary's technology is making waves in revolutionizing patient care. Ambient listening tools, designed to discreetly capture and analyze real-time conversations, empower healthcare providers to focus on patient interactions while automatically documenting clinical notes.
Henry O'Connell, co-founder and CEO of Canary Speech, expressed his commitment to driving change in healthcare through pioneering vocal biomarkers and ambient listening. The company's technology is not only transforming patient care by identifying early signs of mental health and neurological conditions but also extending its reach to support healthcare professionals facing burnout. By analyzing physicians' voices during patient interactions, Canary can pinpoint potential burnout symptoms, enabling healthcare systems to proactively support their staff.
The American Medical Association reports a concerning rise in physician burnout, with nearly 63 percent of physicians experiencing symptoms by the end of 2021. Through ambient listening, Canary is not only assessing patients' health but also evaluating physicians' well-being, paving the way for proactive support within healthcare systems.
With this latest funding injection, Canary is poised to accelerate its growth trajectory by expanding its team and scaling its cloud-based platform. The company's mission to drive change in the healthcare landscape with scalable technology and a top-notch team has garnered support from industry leaders like Cortes Capital. Canary Speech's innovative approach to leveraging vocal biomarkers and ambient listening is set to reshape the future of healthcare, one voice at a time.
Canary's vocal biomarker technology, with its API-first approach, boasts a myriad of applications within the healthcare realm. From contact centers to ambient clinical listening, remote patient monitoring, and annual wellness checks, Canary's technology is making waves in revolutionizing patient care. Ambient listening tools, designed to discreetly capture and analyze real-time conversations, empower healthcare providers to focus on patient interactions while automatically documenting clinical notes.
Henry O'Connell, co-founder and CEO of Canary Speech, expressed his commitment to driving change in healthcare through pioneering vocal biomarkers and ambient listening. The company's technology is not only transforming patient care by identifying early signs of mental health and neurological conditions but also extending its reach to support healthcare professionals facing burnout. By analyzing physicians' voices during patient interactions, Canary can pinpoint potential burnout symptoms, enabling healthcare systems to proactively support their staff.
The American Medical Association reports a concerning rise in physician burnout, with nearly 63 percent of physicians experiencing symptoms by the end of 2021. Through ambient listening, Canary is not only assessing patients' health but also evaluating physicians' well-being, paving the way for proactive support within healthcare systems.
With this latest funding injection, Canary is poised to accelerate its growth trajectory by expanding its team and scaling its cloud-based platform. The company's mission to drive change in the healthcare landscape with scalable technology and a top-notch team has garnered support from industry leaders like Cortes Capital. Canary Speech's innovative approach to leveraging vocal biomarkers and ambient listening is set to reshape the future of healthcare, one voice at a time.